{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zhang Y"],"funding":["the National Key R&D Program of China","the Key Science and Technology Program of Wenzhou","the National Natural Science Foundation of China"],"pagination":["e190682"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12288978"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10(14)"],"pubmed_abstract":["BACKGROUNDTraumatic optic neuropathy (TON) is a leading cause of blindness following closed traumatic brain injury, with no effective treatments available. Previous interventional clinical trials were complicated by its low prevalence, variability in neurodegenerative severity, and unavailability of reliable biomarkers.METHODSWe analyzed data from 1,226 patients enrolled in the prospective National Multi-Center Collaborative Clinical Research Program of China (2017-2024) to establish a clinical profile and identify noninvasive biomarkers for neurodegenerative severity. Subgroup analysis of patients with monocular TON revealed potential biomarkers, including visual functional parameters, inner retinal thickness, and time postinjury.RESULTSThe ganglion cell complex (GCC) thickness showed a s"],"journal":["JCI insight"],"pubmed_title":["Large-scale survey, animal models, and computational modeling identify histological neurodegenerative biomarkers for traumatic optic neuropathy."],"pmcid":["PMC12288978"],"funding_grant_id":["82471080","2022YFA1105500","ZY2022021"],"pubmed_authors":["Liu H","Zhang K","Liu M","Wang C","Jia B","Wu E","Shi Z","Xiong W","Zheng J","Wang R","Xu B","Wei S","Ge Z","Kang J","Yu Z","Wu W","Wang Z","Deng X","Li G","An N","Chen L","Chen H","Yan W","Chen D","Huang S","Zhang Y","Luo Y","Tu Y","Shi H","Liu G"],"additional_accession":[]},"is_claimable":false,"name":"Large-scale survey, animal models, and computational modeling identify histological neurodegenerative biomarkers for traumatic optic neuropathy.","description":"BACKGROUNDTraumatic optic neuropathy (TON) is a leading cause of blindness following closed traumatic brain injury, with no effective treatments available. Previous interventional clinical trials were complicated by its low prevalence, variability in neurodegenerative severity, and unavailability of reliable biomarkers.METHODSWe analyzed data from 1,226 patients enrolled in the prospective National Multi-Center Collaborative Clinical Research Program of China (2017-2024) to establish a clinical profile and identify noninvasive biomarkers for neurodegenerative severity. Subgroup analysis of patients with monocular TON revealed potential biomarkers, including visual functional parameters, inner retinal thickness, and time postinjury.RESULTSThe ganglion cell complex (GCC) thickness showed a s","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jul","modification":"2026-03-17T15:36:41.025Z","creation":"2025-08-17T03:06:08.89Z"},"accession":"S-EPMC12288978","cross_references":{"pubmed":["40526586"],"doi":["10.1172/jci.insight.190682"]}}